University of Mannheim
Also known as: Centre for Rhinology and Allergology of University Hospital Mannheim | Dep. Medicine II, University hospital Mannheim | Dep of Ophthalmology, University of Mannheim | III. Medizinische Klinik Mannheim | Onkologisches Zentrum III, Medizinische Klinik, Mannheim, Germany | Ralf Hofheinz | Skin Cancer Unit, German Cancer Research Center Heidelberg and Department of Dermatology, University Hospital of Mannheim, Mannheim, Germany | Universitaetsmedizin Mannheim | Universitätsmedizin Mannheim | Universitätsmedizin Mannheim, Tagestherapiezentrum am ITM | University Centre Mannheim and Heidelberg | University Hospital Mannheim | University Hospital Mannheim, Department of Surgery | University Medical Center Mannheim | University Medical Centre Mannheim | University of Mannheim, General Surgery | ZI Mannheim, Department of Clinical Psychology, RG Psychology and Neurobiology of Sleep and Memory
Highest phase reached
Phase 4
First clinical trial
Jan 1, 1995Last known activity
Feb 20, 2026
Timeline
1960s
- Jan 1, 1967
University of Mannheim— Founded
Drugs by trial phase (54 distinct, 36 trials)
Phase 4 (9 own, 0 via acquisition)
Phase 3 (22 own, 0 via acquisition)
Phase 2 (14 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Angina Pectoris
- Angina, Stable
- Angina, Unstable
- Asthma
- Central Nervous System Neoplasms
- Colorectal Neoplasms
- Conjunctivitis
- Coronary Disease
- Dermatofibrosarcoma
- Diabetic Retinopathy
- Edema
- Gastroesophageal Reflux
- Gastrointestinal Stromal Tumors
- Glioblastoma
- Heartburn
- Hemangiosarcoma
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Chronic-Phase
- Liposarcoma
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Cutaneous
- Macular Edema
- Nervous System Neoplasms
- Pancreatic Neoplasms
- Rectal Neoplasms
- Rhinitis
- Rhinitis, Allergic
- Sarcoma
- Schizophrenia
- Signs and Symptoms
- Stomach Neoplasms
- Waldenstrom Macroglobulinemia
Recent trials (50)
- NCT06978062OfficialPhase 1Feb 20, 2026
- NCT06137378CollaboratorPhase 2Nov 30, 2024
- NCT05690048CollaboratorPhase 2Jan 1, 2024
- NCT05189379Overall official - principal investigatorN/AMar 10, 2022
- NCT04495088Lead sponsorPhase 3Sep 30, 2020
- NCT04495088Sponsor investigatorPhase 3Sep 30, 2020
- NCT04495088Overall official - principal investigatorPhase 3Sep 30, 2020
- NCT04375605Reponsible party - principal investigatorPhase 3May 31, 2020
- NCT04375605Lead sponsorPhase 3May 31, 2020
- NCT04375605Overall official - principal investigatorPhase 3May 31, 2020
- NCT03530267Overall official - principal investigatorPhase 2Sep 15, 2018
- NCT03063541Lead sponsorPhase 3Sep 21, 2017
- NCT03063541Reponsible party - principal investigatorPhase 3Sep 21, 2017
- NCT03063541Sponsor investigatorPhase 3Sep 21, 2017
- NCT03171389CollaboratorPhase 2Mar 22, 2017
Details
- Founded
- Mannheim, DE Jan 1, 1967
- Last known activity
- Feb 20, 2026